Skip to main content

Selected Publications

For publications, please select from the topics below.

  1. The Early Detection of Oral Cancer Working Group. Guideline for the Early Detection of Oral Cancer in British Columbia 2008. Journal of Canadian Dental Association. (In press, April 2008)
  2. Rosin, M.P., Poh, C., Elwood, M., Williams, M., Gallagher, R., MacAulay, C., Lam, W.L., Auluck, A., Zhang, L., and Hislop, G. New Hope for Oral Cancer Solutions: Together We Can Make a Difference. Journal of Canadian Dental Association (In press, April 2008)
  3. Rosin, M.P., Poh, C.F., Guillaud, M, Williams, M, Zhang, L and MacAulay, C. Visualization and other emerging technologies as changes-makers for oral cancer prevention. Annals of New York Academy of Science. 1098: 167-183 (2007).
  1. Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M,. Trends in oral and oropharyngeal cancer in a multicultural region: the BC experience. Cancer. Cancer. 2010 Jun 1;116(11):2635-44.
  2. Auluck A, Hislop G, Poh C, Zhang L, Rosin MP. Areca nut and betel quid chewing among South Asian immigrants to Western countries and its implications for oral cancer screening. Rural Remote Health. 2009 Apr-Jun;9(2):1118. Epub 2009 May 14.
  3. Auluck A, Miriam R, Hislop G. Oral cancer awareness among the immigrant Indo-Canadian community in Vancouver, BC. Rural and Remote Health 2008; 8; 1004
  4. Auluck A, Rosin M, Zhang L, Sumanth KN. Oral submucous fibrosis: clinically benign but potentially malignant disease - report of 3 cases and review of literature. J Can Dent Assoc. 2008; 74(8):735-40.
  5. Biggar, H., Poh, C.F., Rosin, M.P., and Williams, M. The Voice of An Oral Cancer Patient. Journal of Canadian Dental Association. (In press, April 2008)
  6. Laronde, D., Bottorff, J., Hislop, G., Poh, C.F., Currie, B., Williams, M., and Rosin, M.P. Experiences from the Dental Office: Initiating Oral Cancer Screening. Journal of Canadian Dental Association (In press, April 2008)
  7. Laronde, D., Hislop, G., Elwood, M., and Rosin, M.P. Oral Cancer: Just the Facts. Journal of Canadian Dental Association (In press, April 2008)
  8. Musa, Z., Johnston, K., Peacock, S., Rosin, M.P., and Elwood, M. Why Should Dentists Screen for Oral Cancer. Journal of Canadian Dental Association (In press, April 2008)
  9. Poh, C.F., Ng, S., Berean, K., Williams, M., Rosin, M.P., and Zhang, L. Biopsy and Histopathological Diagnosis of Oral Premalignant and Malignant Lesions. Journal of Canadian Dental Association (In press, April 2008)
  10. Poh, C.F., Hislop, T.G., Currie, B., Lee, R., Sikorski, S., Zed, C., Zhang, L., MacAulay, C. and Rosin, M.P. Oral cancer screening in a high-risk underserved community – Vancouver Downtown Eastside. Journal of Health Care for the Poor and Underserved. 18:767-778 (2007).
  11. Poh, C.F., Currie, B., Hislop, T.G., Bottorff, J., Zhang, L., MacAulay, C. and Rosin, M.P. Moving oral cancer screening to “comfort zones” in the Vancouver downtown eastside, a high-risk underserved community. National Forum on Cancer Care for All Canadians Improving Access & Minimizing Disparities. In press, November (2007).
  12. Laronde, D., Poh, C.F., Williams, M., Hislop, T.G., Zhang, L., MacAulay, C., and Rosin, M.P. A magic wand for the community dental office? Observations from the British Columbia Oral Cancer Prevention Program. JCDA, 73(7): 607-609 (2007).
  13. Poh, C.F., Williams, P.M., Zhang, L., Rosin, M.P. Heads Up! – A Call for Dentists to Screen for Oral Cancer. Journal of the Canadian Dental Association. 72(5):413-416 (2006).
  14. Epstein, J.B., Zhang, L. and Rosin, M.P. Advances in the diagnosis of oral premalignant and malignant lesions. JCDA, 68(10): 617-621 (2002).
  15. Zhang, L. and Rosin, M.P. Two sides of a prevention ‘coin’: adequate screening and better tools. Letter to the Editor. J. Oral Path. Med., 31(4): 249-50 (2002).
  1. Zhang, L., Williams, M., Poh, C.F., Laronde, D., Epstein, J.B., Durham, S., Nakamura, H., Berean, K., Hovan, A., Le, N.D., Hislop, G., Priddy, R., Hay, J., Lam, W.L. and Rosin, M.P. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 65(17): 8017-8021 (2005). 
  2. Epstein, J.B., Zhang, L., Poh, C., Nakamura, H. and Berean, K. and Rosin, M.P. Increased allelic loss in toluidine blue positive oral premalignant lesions. Oral Surgery Oral Med. Oral Pathol., 95: 45-50 (2003).
  1. Ng, S., Poh, C.F., Williams, M., Zhang, L., MacAulay, C., and Rosin, M.P. Use of Direct Fluorescence Visualization to Identify High-Risk Oral Pre-malignant Lesions in British Columbia: Update. Inside Dentistry, 3 (4, Supplement), 199:19-20 (2007). 
  2. Poh, C.F., Ng, S.P., Williams, P.M., Zhang, L., Laronde, D.M., Lane, P., MacAulay, C. and Rosin, M.P. Direct Fluorescence Visualization of Clinically Occult High-Risk Oral Premalignant Disease Using A Simple Hand-Held Device. Head & Neck. 29 (1): 71-76 (2006). 
  3. Poh, C.F., Zhang, L., Anderson, D.W., Durham, S., Williams, P.M., Priddy, R.W., Berean, K.W., Ng, S., Tseng, O.L., MacAulay, C. and Rosin, M.P. Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients. Clinical Cancer Res 12(22): 6716-6722 (2006). 
  4. Lane, P.M., Gilhuly, T., Whitehead, P., Zeng, H., Poh, C., Ng, S., Williams, M., Zhang, L., Rosin, M.P. and MacAulay, C.E. Simple device for the direct visualization of oral-cavity tissue fluorescence. Journal of Biomedical Optics. 11(2):024006-1--024006-7 (2006).
  1. Tsui, I.F.L., Rosin, M.P., Zhang, L., Ng, R.T. and Lam, W. Frequent genetic alterations occurring in oral premalignant lesions: analysis of chromosome 3p. Cancer Research, in review. 
  2. Guillaud, M., Zhang, L., Poh, C., Rosin, M.P., and MacAulay, C.  Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions. Cancer Research, in press.
  3. Garnis, C., Rosin, M.P., Zhang, L. and Lam, W.L. Alteration of AKAP220, an upstream component of the Rb pathway, in oral carcinogenesis. Int. J. Cancer, 116(5): 813-9 (2005).
  4. Garnis C., Coe, B.P., Zhang, L., Rosin, M.P. and Lam, W.L. Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene, 23: 2582-2586 (2004). 
  5. Garnis, C., Baldwin, C., Zhang, L., Rosin, M.P. and Lam, W.L. Use of complete coverage array CGH to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Research, 63: 8582-8585 (2003).
  6. Garnis, C., Coe, B.P., Ishkanian, A., Zhang, L., Rosin, M.P. and Lam, W.L. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes, Chromosome & Cancer, 39: 93-98 (2003). 
  7. Rosin, M.P., Lam, W.L and Zhang, L. Correspondence re: M.P. Rosin et al., 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res., 62, 6447-6450, 2002. Reply. Cancer Res., 63: 5168-5169 (2003).
  8. Baldwin, C., Garnis, C., Zhang, L., Rosin, M. and Lam, W.L. Genomic Analysis of Tumors by Array Comparative Genomic Hybridization: More is Better. Cancer Research. 66(7): 3955-3956 (2006). 
  9. Baldwin, C., Garnis, C., Zhang, L., Rosin, M.P. and Lam, W.L. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65(17): 7561-7567 (2005). 
  10. Garnis, C., Campbell, J., Zhang, L., Rosin, M.P. and Lam, W.L. OCGR array, an oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncology, 40: 511-519 (2004).
  11. Rosin, M.P., Zhang, L. and Poh, C. Molecular markers of oral premalignant lesion risk. In:Head and Neck Cancer – Emerging Prospectives, J.F. Ensley, J. S. Gutkind, J.R. Jacobs and S.M. Lippman, (eds), Academic Press, Calif., pp.245-259 (2003).
  12. Siwoski, A., Ishkanian, A., Garnis, C., Zhang, L., Rosin, M. and Lam, W.L. An efficient method for the assessment of DNA quality of archival microdissected specimens. Modern Pathology, 15(8): 889-892 (2002).
  13. Zhang, L., Epstein, J.B., Poh, C.F., Berean, K., Lam, W.L., Zhang, X. and Rosin, M.P. Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-post-transplant oral squamous cell carcinomas. J. Oral Path. Med., 31(3): 134-141 (2002).
  14. Poh, C.F., Zhang, L., Lam, W., Zhang, X., Ding, A., Chau, C., Priddy, R., Epstein, J. and Rosin, M.P. A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab. Investigations, 81: 629-634 (2001).
  15. Rosin, M.P., Cheng, X., Poh, C., Lam, W.L., Huang, Y., Lovas, J., Berean, K., Epstein, J.B., Priddy, R., Le, N.D. and Zhang, L. Use of allelic loss to predict malignant risk of low-grade oral epithelial dysplasias. Clin. Cancer Res., 6(2): 357-362 (2000).

RefWorks updated list of all publications.

SOURCE: Selected Publications ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2024 Provincial Health Services Authority